CD8A and non-small cell lung carcinoma: Additionally, compared to control samples, NSCLC exhibited a higher concentration of CD8+ T cells (Figure 3D), which aligned with the results of KM survival analysis from the TCGA‐NSCLC dataset and underscored the critical role of CD8+ T cells in the immune defense against NSCLC.